-
1
-
-
0035722519
-
Maintenance immunosuppression in the renal transplant recipient: An overview
-
Gaston R: Maintenance immunosuppression in the renal transplant recipient: An overview. Am J Kidney Dis 2001;38(suppl 6):S25-S35.
-
(2001)
Am J Kidney Dis
, vol.38
, Issue.6 SUPPL.
-
-
Gaston, R.1
-
2
-
-
0036802558
-
Universal approach to pharmacokinetics monitoring of immunosuppressive agents in children
-
Filler G, Feber J, Lepage N, Weiler G, Mai I: Universal approach to pharmacokinetics monitoring of immunosuppressive agents in children. Pediatr Transplant 2002;6:411-418.
-
(2002)
Pediatr Transplant
, vol.6
, pp. 411-418
-
-
Filler, G.1
Feber, J.2
Lepage, N.3
Weiler, G.4
Mai, I.5
-
3
-
-
0034897144
-
Current issues in therapeutic drug monitoring of mycophenolate acid: Report of a round table discussion
-
Shaw L, Holt D, Oellerich M, Meiser B, van Gelder T: Current issues in therapeutic drug monitoring of mycophenolate acid: Report of a round table discussion. Ther Drug Monit 2001;23:305-315.
-
(2001)
Ther Drug Monit
, vol.23
, pp. 305-315
-
-
Shaw, L.1
Holt, D.2
Oellerich, M.3
Meiser, B.4
Van Gelder, T.5
-
4
-
-
0030717563
-
Prediction of cyclosporine area under the curve using a three point sampling strategy after Neoral administration
-
Gaspari F, Anedda MF, Signorini G, Remuzzi G, Perico N: Prediction of cyclosporine area under the curve using a three point sampling strategy after Neoral administration. J Am Soc Nephrol 1997;8:647-652.
-
(1997)
J Am Soc Nephrol
, vol.8
, pp. 647-652
-
-
Gaspari, F.1
Anedda, M.F.2
Signorini, G.3
Remuzzi, G.4
Perico, N.5
-
5
-
-
0032716908
-
Current opinions on therapeutic drug monitoring of immunosuppressive drugs
-
Shaw L, Holt D, Keown P, Venkataramanan R, Yascoff R: Current opinions on therapeutic drug monitoring of immunosuppressive drugs. Clin Ther 1999;21:1632-1652.
-
(1999)
Clin Ther
, vol.21
, pp. 1632-1652
-
-
Shaw, L.1
Holt, D.2
Keown, P.3
Venkataramanan, R.4
Yascoff, R.5
-
6
-
-
0028079609
-
Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a cross-over comparison with the market formulation
-
Mueller EA, Kovarik JM, van Bree JB, Tetzloff W, Grevel J, Kutz K: Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a cross-over comparison with the market formulation. Pharm Res 1994;11:151-155.
-
(1994)
Pharm Res
, vol.11
, pp. 151-155
-
-
Mueller, E.A.1
Kovarik, J.M.2
Van Bree, J.B.3
Tetzloff, W.4
Grevel, J.5
Kutz, K.6
-
7
-
-
0028952478
-
Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals
-
Kahan BD, Dunn J, Fitts C, van Buren D, Wombold D, Pollack R, Carson R, Alexander JW, Choc M, Wong R: Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995;59:505-511.
-
(1995)
Transplantation
, vol.59
, pp. 505-511
-
-
Kahan, B.D.1
Dunn, J.2
Fitts, C.3
Van Buren, D.4
Wombold, D.5
Pollack, R.6
Carson, R.7
Alexander, J.W.8
Choc, M.9
Wong, R.10
-
8
-
-
0034192312
-
Pharmacokinetics validation of Neoral absorption profiling
-
Johnston A, David OJ, Cooney GF: Pharmacokinetics validation of Neoral absorption profiling. Transplant Proc 2000;32:S53-S56.
-
(2000)
Transplant Proc
, vol.32
-
-
Johnston, A.1
David, O.J.2
Cooney, G.F.3
-
9
-
-
0032846279
-
Inhibition of stimulated interleukin-2 production in whole blood: A practical measure of cyclosporine effect
-
Steiner CM, Murray JJ, Wood AJ: Inhibition of stimulated interleukin-2 production in whole blood: A practical measure of cyclosporine effect. Clin Chem 1999;45:1477-1484.
-
(1999)
Clin Chem
, vol.45
, pp. 1477-1484
-
-
Steiner, C.M.1
Murray, J.J.2
Wood, A.J.3
-
10
-
-
0033565808
-
Neoral monitoring by simplified sparse sampling area under the concentration-tune curve
-
Mahalati K, Belitsky P, Sketris I, West K, Panek R: Neoral monitoring by simplified sparse sampling area under the concentration-tune curve. Transplantation 1999;68:55-62.
-
(1999)
Transplantation
, vol.68
, pp. 55-62
-
-
Mahalati, K.1
Belitsky, P.2
Sketris, I.3
West, K.4
Panek, R.5
-
11
-
-
0036785209
-
Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts
-
Pescovitz MD, Barbeito R, Simulect US01 Study Group: Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts. Clin Transplant 2002;16:378-382.
-
(2002)
Clin Transplant
, vol.16
, pp. 378-382
-
-
Pescovitz, M.D.1
Barbeito, R.2
-
12
-
-
0035960050
-
Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation
-
Canadian Neoral Renal Transplantation Study Group: Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation. Transplantation 2001;72:1024-1032.
-
(2001)
Transplantation
, vol.72
, pp. 1024-1032
-
-
-
13
-
-
0003266030
-
Monitoring of 2-hour Neoral absorption in renal transplantation (MO2ART): Interim analysis shows low incidence of acute rejection in the early post-graft period
-
Washington DC, Apr 26-May 1
-
Pfeffer P, Stefoni S, Agost Carreno C, Thervet E, Fornarion S, Keown P, MO2ART Study Group: Monitoring of 2-hour Neoral absorption In renal transplantation (MO2ART): Interim analysis shows low incidence of acute rejection in the early post-graft period. Abstract 1037 Am Soc Transpl Congress, Washington DC, Apr 26-May 1, 2002.
-
(2002)
Abstract 1037 Am Soc Transpl Congress
-
-
Pfeffer, P.1
Stefoni, S.2
Agost Carreno, C.3
Thervet, E.4
Fornarion, S.5
Keown, P.6
-
14
-
-
0035670894
-
C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients
-
Citterio F, Scata MC, Borzi MT, Pozzetto U, Castagneto M: C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients. Transplant Proc 2001;33:3133-3136.
-
(2001)
Transplant Proc
, vol.33
, pp. 3133-3136
-
-
Citterio, F.1
Scata, M.C.2
Borzi, M.T.3
Pozzetto, U.4
Castagneto, M.5
-
15
-
-
0037093506
-
Clinical validation studies of Neoral C2 monitoring: A review
-
Nashan B, Cole E, Levy G, Thervet E: Clinical validation studies of Neoral C2 monitoring: A review. Transplantation 2002;73(suppl):S3-S11.
-
(2002)
Transplantation
, vol.73
, Issue.SUPPL.
-
-
Nashan, B.1
Cole, E.2
Levy, G.3
Thervet, E.4
-
16
-
-
0037093525
-
Patient management by Neoral C2 monitoring: An international consensus statement
-
Levy G, Thervet E, Lake J, Uchida K, on behalf of the CONCERT Group: Patient management by Neoral C2 monitoring: An international consensus statement. Transplantation 2002;73(suppl 9):S12-S18.
-
(2002)
Transplantation
, vol.73
, Issue.9 SUPPL.
-
-
Levy, G.1
Thervet, E.2
Lake, J.3
Uchida, K.4
-
17
-
-
0006198155
-
Therapeutic drug monitoring of immunosuppressant drugs in clinical practice
-
Kahan BD, Keown P, Levy GA, Johnston A: Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther 2000;24:1-21.
-
(2000)
Clin Ther
, vol.24
, pp. 1-21
-
-
Kahan, B.D.1
Keown, P.2
Levy, G.A.3
Johnston, A.4
-
18
-
-
0029586398
-
Clinical pharmacokinetics of Tacrolimus
-
Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T: Clinical pharmacokinetics of Tacrolimus. Clin Pharmacokinet 1995;29:404-430.
-
(1995)
Clin Pharmacokinet
, vol.29
, pp. 404-430
-
-
Venkataramanan, R.1
Swaminathan, A.2
Prasad, T.3
Jain, A.4
Zuckerman, S.5
Warty, V.6
McMichael, J.7
Lever, J.8
Burckart, G.9
Starzl, T.10
-
19
-
-
0038684549
-
Pharmacokinetics of Tacrolimus-based therapies
-
Undre NA: Pharmacokinetics of Tacrolimus-based therapies. Nephrol Dial Transplant 2003;18(suppl 1):i12-i15.
-
(2003)
Nephrol Dial Transplant
, vol.18
, Issue.1 SUPPL.
-
-
Undre, N.A.1
-
20
-
-
0029849460
-
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation
-
Kershner RP, Fitzsimmons WE: Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation 1996;62:920-926.
-
(1996)
Transplantation
, vol.62
, pp. 920-926
-
-
Kershner, R.P.1
Fitzsimmons, W.E.2
-
21
-
-
0032986187
-
Low systemic exposure to tacrolimus correlates with acute rejection
-
Undre NA, van Hooff J, Christiaans M, Vanrenterghem Y, Donck J, Heemann U, Kohnle M, Zanker B, Land W, Morales JM, Andres A, Schafer A, Stevenson P: Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc 1999;31:296-298.
-
(1999)
Transplant Proc
, vol.31
, pp. 296-298
-
-
Undre, N.A.1
Van Hooff, J.2
Christiaans, M.3
Vanrenterghem, Y.4
Donck, J.5
Heemann, U.6
Kohnle, M.7
Zanker, B.8
Land, W.9
Morales, J.M.10
Andres, A.11
Schafer, A.12
Stevenson, P.13
-
22
-
-
0030836803
-
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group
-
Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E: Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997;64:436-443.
-
(1997)
Transplantation
, vol.64
, pp. 436-443
-
-
Mayer, A.D.1
Dmitrewski, J.2
Squifflet, J.P.3
Besse, T.4
Grabensee, B.5
Klein, B.6
Eigler, F.W.7
Heemann, U.8
Pichlmayr, R.9
Behrend, M.10
Vanrenterghem, Y.11
Donck, J.12
Van Hooff, J.13
Christiaans, M.14
Morales, J.M.15
Andres, A.16
Johnson, R.W.17
Short, C.18
Buchholz, B.19
Rehmert, N.20
Land, W.21
Schleibner, S.22
Forsythe, J.L.23
Talbot, D.24
Pohanka, E.25
more..
-
23
-
-
0032704588
-
Pharmacokinetics of Tacrolimus: Clinically relevant aspects
-
Undre NA, Stevenson P, Schafer A: Pharmacokinetics of Tacrolimus: Clinically relevant aspects. Transplant Proc 1999:31(suppl 7):S21-S24.
-
(1999)
Transplant Proc
, vol.31
, Issue.7 SUPPL.
-
-
Undre, N.A.1
Stevenson, P.2
Schafer, A.3
-
24
-
-
0035993643
-
Effect of bile flow on the absorption of Tacrolimus in liver allograft transplantation
-
Bottiger Y, Undre NA, Sawe J, Stevenson PJ, Ericzon BG: Effect of bile flow on the absorption of Tacrolimus in liver allograft transplantation. Transplant Proc 2002;34:1544-1545.
-
(2002)
Transplant Proc
, vol.34
, pp. 1544-1545
-
-
Bottiger, Y.1
Undre, N.A.2
Sawe, J.3
Stevenson, P.J.4
Ericzon, B.G.5
-
25
-
-
0029917782
-
Pharmacokinetics of mycophenolate mofetil (RS61443): A short review
-
Bullingham RES, Nicholls A, Hale M: Pharmacokinetics of mycophenolate mofetil (RS61443): A short review. Transplant Proc 1996;28:925-929.
-
(1996)
Transplant Proc
, vol.28
, pp. 925-929
-
-
Bullingham, R.E.S.1
Nicholls, A.2
Hale, M.3
-
26
-
-
0033609476
-
A randomized double-blind multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation
-
van Gelder T, Hilbrands LB, Vanrenterghem Y, Weimar W, de Fijter JW, Squifflet JP, Hené RJ, Verpooten GA, Navarro MT, Hale MD, Nicholls AJ: A randomized double-blind multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1998;68:261-266.
-
(1998)
Transplantation
, vol.68
, pp. 261-266
-
-
Van Gelder, T.1
Hilbrands, L.B.2
Vanrenterghem, Y.3
Weimar, W.4
De Fijter, J.W.5
Squifflet, J.P.6
Hené, R.J.7
Verpooten, G.A.8
Navarro, M.T.9
Hale, M.D.10
Nicholls, A.J.11
-
27
-
-
0033981118
-
Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation
-
Shaw LM, Kaplan B, DeNofrio D, Korecka M, Brayman ICL: Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit 2000;22:14-19.
-
(2000)
Ther Drug Monit
, vol.22
, pp. 14-19
-
-
Shaw, L.M.1
Kaplan, B.2
DeNofrio, D.3
Korecka, M.4
Brayman, I.C.L.5
-
28
-
-
0029058395
-
Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics
-
Nowak I, Shaw LM: Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics. Clin Chem 1995;41:1011-1017.
-
(1995)
Clin Chem
, vol.41
, pp. 1011-1017
-
-
Nowak, I.1
Shaw, L.M.2
-
29
-
-
0033668361
-
Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable
-
Shaw LM, Korecka M, Aradhye S, Grossman R, Bayer L, Innes C, Cucciara A, Barker C, Naji A, Nicholls A, Brayman K: Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol 2000;40:624-633.
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 624-633
-
-
Shaw, L.M.1
Korecka, M.2
Aradhye, S.3
Grossman, R.4
Bayer, L.5
Innes, C.6
Cucciara, A.7
Barker, C.8
Naji, A.9
Nicholls, A.10
Brayman, K.11
-
30
-
-
0032128401
-
Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection
-
Nicholls AJ: Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/ pharmacodynamic relationship for mycophenolic acid and suppression of rejection. Clin Biochem 1998;31:329-333.
-
(1998)
Clin Biochem
, vol.31
, pp. 329-333
-
-
Nicholls, A.J.1
-
31
-
-
0032128067
-
Therapeutic monitoring of mycophenolic acid: A consensus panel report
-
Shaw LM, Nicholls A, Hale M, Armstrong VW, Oellerich M, Yatscoff R, Morris RE, Holt DW, Venkataraman R, Haley J, Halloran P, Ettenger R, Keown P, Morris RG: Therapeutic monitoring of mycophenolic acid: A consensus panel report. Clin Biochem 1998;31:317-322.
-
(1998)
Clin Biochem
, vol.31
, pp. 317-322
-
-
Shaw, L.M.1
Nicholls, A.2
Hale, M.3
Armstrong, V.W.4
Oellerich, M.5
Yatscoff, R.6
Morris, R.E.7
Holt, D.W.8
Venkataraman, R.9
Haley, J.10
Halloran, P.11
Ettenger, R.12
Keown, P.13
Morris, R.G.14
-
32
-
-
0033797428
-
Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients
-
Willis C, Taylor PJ, Salm P, Tett SE, Pillans PI: Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients. Ther Drug Monit 2000;22:549-554.
-
(2000)
Ther Drug Monit
, vol.22
, pp. 549-554
-
-
Willis, C.1
Taylor, P.J.2
Salm, P.3
Tett, S.E.4
Pillans, P.I.5
-
33
-
-
2442712496
-
Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is prefereable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy
-
Filler G: Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is prefereable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy. Transpl Int 2004;17:120-125.
-
(2004)
Transpl Int
, vol.17
, pp. 120-125
-
-
Filler, G.1
-
34
-
-
0037663784
-
The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation
-
Pelletier RP, Akin B, Henry ML, Bumgardner GL, Elkhammas EA, Rajab A, Ferguson RM: The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 2003;17:200-205.
-
(2003)
Clin Transplant
, vol.17
, pp. 200-205
-
-
Pelletier, R.P.1
Akin, B.2
Henry, M.L.3
Bumgardner, G.L.4
Elkhammas, E.A.5
Rajab, A.6
Ferguson, R.M.7
-
35
-
-
0042536429
-
Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation
-
Knoll GA, Mac Donald I, Khan A, van Walraven C: Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 2003;14:2381-2386.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2381-2386
-
-
Knoll, G.A.1
Mac Donald, I.2
Khan, A.3
Van Walraven, C.4
-
36
-
-
0033376927
-
Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipient
-
Kelly PA, Napoli KL, Kahan BD: Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipient. Biopharm Drug Dispos 2000;20:249-253.
-
(2000)
Biopharm Drug Dispos
, vol.20
, pp. 249-253
-
-
Kelly, P.A.1
Napoli, K.L.2
Kahan, B.D.3
-
37
-
-
0031008434
-
Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration
-
Zimmerman JJ, Kahan BD: Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol 1997;37:405-415.
-
(1997)
J Clin Pharmacol
, vol.37
, pp. 405-415
-
-
Zimmerman, J.J.1
Kahan, B.D.2
-
38
-
-
0038298948
-
Therapeutic monitoring of sirolimus: Its contribution to optimal prescription
-
Holt DW, Denny K, Lee TD, Johnston A: Therapeutic monitoring of sirolimus: Its contribution to optimal prescription. Transplant Proc 2003;35(suppl 3):S157-S161.
-
(2003)
Transplant Proc
, vol.35
, Issue.3 SUPPL.
-
-
Holt, D.W.1
Denny, K.2
Lee, T.D.3
Johnston, A.4
-
39
-
-
2942560551
-
Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients
-
Oellerich M, Armstrong V, Streit F, Weber L, Tonshoff B: Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients. Clin Biochem 2004;37:624-628.
-
(2004)
Clin Biochem
, vol.37
, pp. 624-628
-
-
Oellerich, M.1
Armstrong, V.2
Streit, F.3
Weber, L.4
Tonshoff, B.5
-
40
-
-
0033610455
-
A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients
-
Kahan BD, Wong RL, Carter C, Katz SH, von Fellenberg J, van Buren CT, Appel-Dingemanse S: A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1999;68:1100-1106.
-
(1999)
Transplantation
, vol.68
, pp. 1100-1106
-
-
Kahan, B.D.1
Wong, R.L.2
Carter, C.3
Katz, S.H.4
Von Fellenberg, J.5
Van Buren, C.T.6
Appel-Dingemanse, S.7
-
41
-
-
0036138190
-
Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: A clinically relevant pharmacokinetic interaction
-
Kovaric JM, Kalbag J, Figueiredo J, Rouilly M, Frazier OL, Rordorf C: Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: A clinically relevant pharmacokinetic interaction. J Clin Pharmacol 2002;42:95-99.
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 95-99
-
-
Kovaric, J.M.1
Kalbag, J.2
Figueiredo, J.3
Rouilly, M.4
Frazier, O.L.5
Rordorf, C.6
-
43
-
-
0037181426
-
Exposure-response relationship for everolimus in de novo kidney transplantation: Defining a therapeutic range
-
Kovarik JM, Kaplan B, Tedesco Silva H, Kahan BD, Dantal J, Vitko S, Boger R, Rordorf C: Exposure-response relationship for everolimus in de novo kidney transplantation: Defining a therapeutic range. Transplantation 2002;73:920-925.
-
(2002)
Transplantation
, vol.73
, pp. 920-925
-
-
Kovarik, J.M.1
Kaplan, B.2
Tedesco Silva, H.3
Kahan, B.D.4
Dantal, J.5
Vitko, S.6
Boger, R.7
Rordorf, C.8
-
44
-
-
0027994206
-
FK506 metabolism in human liver microsomes: Investigation of the involvment of cytochrome P450 isoenzymes other than CYP3A4
-
Karanam BV, Vincent SH, Newton DJ, Wang RW, Chiu SH: FK506 metabolism in human liver microsomes: Investigation of the involvment of cytochrome P450 isoenzymes other than CYP3A4. Drug Metab Dispos 1994;22:811-814.
-
(1994)
Drug Metab Dispos
, vol.22
, pp. 811-814
-
-
Karanam, B.V.1
Vincent, S.H.2
Newton, D.J.3
Wang, R.W.4
Chiu, S.H.5
-
45
-
-
4243856813
-
Tacrolimus trough levels increase after steroid withdrawal
-
San Diego, (abstract P88)
-
van Duijnhoven EM, Boots JMM, Christiaans M, Undre NA, van Hooff J: Tacrolimus trough levels increase after steroid withdrawal. 2nd International Congress on Immunosuppression, San Diego, 2001, 133 (abstract P88).
-
(2001)
2nd International Congress on Immunosuppression
, vol.133
-
-
Van Duijnhoven, E.M.1
Boots, J.M.M.2
Christiaans, M.3
Undre, N.A.4
Van Hooff, J.5
-
46
-
-
13144250158
-
Pharmacokinetics of FK506 and mycophenolic acid after the administration of a FK506-based regimen in combination with mycophenolate mofetil in kidney transplantation
-
Undre NA, van Hooff J, Christiaans M, Vanrenterghem Y, Donck J, Heeman U, Kohnle M, Zanker B, Land W, Morales JM, Andres A, Schafer A, Stevenson P: Pharmacokinetics of FK506 and mycophenolic acid after the administration of a FK506-based regimen in combination with mycophenolate mofetil in kidney transplantation. Transplant Proc 1998;30:1299-1302.
-
(1998)
Transplant Proc
, vol.30
, pp. 1299-1302
-
-
Undre, N.A.1
Van Hooff, J.2
Christiaans, M.3
Vanrenterghem, Y.4
Donck, J.5
Heeman, U.6
Kohnle, M.7
Zanker, B.8
Land, W.9
Morales, J.M.10
Andres, A.11
Schafer, A.12
Stevenson, P.13
-
47
-
-
12644290298
-
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and Cellcept in combination therapy
-
Zucker K, Rosen A, Tsaroucha A, de Faria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J: Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and Cellcept in combination therapy. Transplant Proc 1997;29:334-336.
-
(1997)
Transplant Proc
, vol.29
, pp. 334-336
-
-
Zucker, K.1
Rosen, A.2
Tsaroucha, A.3
De Faria, L.4
Roth, D.5
Ciancio, G.6
Esquenazi, V.7
Burke, G.8
Tzakis, A.9
Miller, J.10
-
48
-
-
0344286009
-
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipient
-
Gregoor PJ, de Sevaux RG, Hene RJ, Hesse CJ, Hilbrands LB, Vos P, van Gelder T, Hoitsma AJ, Weimar W: Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipient. Transplantation 1999;68:1603-1606.
-
(1999)
Transplantation
, vol.68
, pp. 1603-1606
-
-
Gregoor, P.J.1
De Sevaux, R.G.2
Hene, R.J.3
Hesse, C.J.4
Hilbrands, L.B.5
Vos, P.6
Van Gelder, T.7
Hoitsma, A.J.8
Weimar, W.9
-
49
-
-
18244427344
-
Sirolimus in association with mycophenolate mofetil in renal transplant recipients
-
Kreis H, Cisterne JM, Land L, Wrammer L, Squifflet JP, Abramowicz D, Campistol JM, Morales JM, Grinyo GM, Mourad G, Berthoux FC, Brattstrom C, Lebranchu Y, Vialtel P: Sirolimus in association with mycophenolate mofetil in renal transplant recipients. Transplantation 2000;69:1252-1260.
-
(2000)
Transplantation
, vol.69
, pp. 1252-1260
-
-
Kreis, H.1
Cisterne, J.M.2
Land, L.3
Wrammer, L.4
Squifflet, J.P.5
Abramowicz, D.6
Campistol, J.M.7
Morales, J.M.8
Grinyo, G.M.9
Mourad, G.10
Berthoux, F.C.11
Brattstrom, C.12
Lebranchu, Y.13
Vialtel, P.14
-
50
-
-
0034065402
-
Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
-
MacDonald A, Scarola J, Burke JT, Zimmerman JJ: Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 2000;22(suppl B):B101-B121.
-
(2000)
Clin Ther
, vol.22
, Issue.SUPPL. B
-
-
MacDonald, A.1
Scarola, J.2
Burke, J.T.3
Zimmerman, J.J.4
-
51
-
-
0038684549
-
Pharmacokinetics of tacrolimus-based combination therapies
-
Undre Na: Pharmacokinetics of tacrolimus-based combination therapies. Nephrol Dial transplant 2003;18(suppl 1):i12-i15.
-
(2003)
Nephrol Dial Transplant
, vol.18
, Issue.1 SUPPL.
-
-
Na, U.1
-
52
-
-
0029817346
-
Toxic effects of immunosuppressive drugs: Mechanism and strategies for controlling them
-
Shaw LM, Kaplan B, Kaufman D: Toxic effects of immunosuppressive drugs: Mechanism and strategies for controlling them. Clin Chem 1996;42:1316-1321.
-
(1996)
Clin Chem
, vol.42
, pp. 1316-1321
-
-
Shaw, L.M.1
Kaplan, B.2
Kaufman, D.3
-
53
-
-
0002379569
-
Established immunosuppressive drugs: Clinical and toxic effects
-
Kahan B, Ponticelli C (eds): London, Martin Dunitz
-
Kahan B, Ponticelli C: Established immunosuppressive drugs: Clinical and toxic effects; in Kahan B, Ponticelli C (eds): Principles and Practice of Renal Transplantation. London, Martin Dunitz, 2000, pp 349-414.
-
(2000)
Principles and Practice of Renal Transplantation
, pp. 349-414
-
-
Kahan, B.1
Ponticelli, C.2
|